Envista Holdings Corp (NVST)
USD 18.2
(-5.41%)
USD 18.2
(-5.41%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.60 USD | -141.1% |
| 2022 | 1.46 USD | -10.43% |
| 2021 | 1.63 USD | 676.19% |
| 2020 | 0.21 USD | -86.88% |
| 2019 | 1.60 USD | 7.38% |
| 2018 | 1.49 USD | -23.59% |
| 2017 | 1.95 USD | 10.8% |
| 2016 | 1.76 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 0.14 USD | 111.02% |
| 2024 Q2 | -6.69 USD | -4878.57% |
| 2024 Q3 | 0.05 USD | 100.71% |
| 2023 FY | - USD | -141.1% |
| 2023 Q3 | 0.13 USD | -59.38% |
| 2023 Q2 | 0.32 USD | 18.52% |
| 2023 Q1 | 0.27 USD | -40.0% |
| 2023 Q4 | -1.27 USD | -1076.92% |
| 2022 FY | - USD | -10.43% |
| 2022 Q4 | 0.45 USD | 66.67% |
| 2022 Q3 | 0.27 USD | 0.0% |
| 2022 Q2 | 0.27 USD | -35.71% |
| 2022 Q1 | 0.42 USD | -20.75% |
| 2021 Q2 | 0.56 USD | 24.44% |
| 2021 FY | - USD | 676.19% |
| 2021 Q3 | 0.58 USD | 3.57% |
| 2021 Q1 | 0.45 USD | -33.82% |
| 2021 Q4 | 0.53 USD | -8.62% |
| 2020 Q3 | 0.23 USD | 138.98% |
| 2020 Q4 | 0.68 USD | 195.65% |
| 2020 FY | - USD | -86.88% |
| 2020 Q1 | -0.11 USD | -131.43% |
| 2020 Q2 | -0.59 USD | -436.36% |
| 2019 Q2 | 0.40 USD | 60.0% |
| 2019 FY | - USD | 7.38% |
| 2019 Q3 | 0.48 USD | 20.0% |
| 2019 Q1 | 0.25 USD | -24.24% |
| 2019 Q4 | 0.35 USD | -27.08% |
| 2018 Q3 | 0.41 USD | -19.61% |
| 2018 Q1 | 0.24 USD | 0.0% |
| 2018 Q2 | 0.51 USD | 112.5% |
| 2018 Q4 | 0.33 USD | -19.51% |
| 2018 FY | - USD | -23.59% |
| 2017 FY | - USD | 10.8% |
| 2016 FY | - USD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Alcon Inc. | 1.98 USD | 130.303% |
| AptarGroup, Inc. | 4.34 USD | 113.825% |
| Baxter International Inc. | 5.25 USD | 111.429% |
| Becton, Dickinson and Company | 5.96 USD | 110.067% |
| Bausch + Lomb Corporation | -0.74 USD | 18.919% |
| Haemonetics Corporation | 2.32 USD | 125.862% |
| ResMed Inc. | 6.94 USD | 108.646% |
| Teleflex Incorporated | 7.58 USD | 107.916% |
| Warby Parker Inc. | -0.54 USD | -11.111% |
| West Pharmaceutical Services, Inc. | 7.99 USD | 107.509% |